Champions Oncology (CSBR) Construction in Progress (2017 - 2020)
Champions Oncology (CSBR) recorded quarterly Construction in Progress of $441000.0 in Q4 2020, up 286.84% quarter-over-quarter from $114000.0 in Q3 2020.
Champions Oncology (CSBR) Construction in Progress (2017 - 2020) Analysis & Trends
Champions Oncology's Construction in Progress history runs 4 years deep, the most recent figure standing at $441000.0 for Q4 2020.
- In Q4 2020, Construction in Progress changed N/A year-over-year to $441000.0; the TTM figure through Oct 2020 stood at $441000.0 (changed N/A YoY), while the FY2020 annual figure was $554000.0, up 3362.5% from the prior year.
- Construction in Progress was $441000.0 for Q4 2020 at Champions Oncology, up from $114000.0 in the prior quarter.
- In the past five years, Construction in Progress ranged from a high of $619000.0 in Q3 2019 to a low of $15000.0 in Q2 2018.
- Historically, Construction in Progress has averaged $196076.9 across 4 years, with a median of $58000.0 in 2018.
- The sharpest annual moves came in 2018 and 2020: Construction in Progress slumped 96.82% in 2018, then jumped 3362.5% in 2020.
- A 4-year view of Construction in Progress shows it stood at $19000.0 in 2017, then jumped by 31.58% to $25000.0 in 2018, then surged by 2376.0% to $619000.0 in 2019, then fell by 28.76% to $441000.0 in 2020.
- The last three Construction in Progress figures came in at $441000.0 (Q4 2020), $114000.0 (Q3 2020), and $554000.0 (Q2 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Champions Oncology | 78.46 Mn | 71.46 Mn | 13.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2020 | 441,000.00 |
| Jul 31, 2020 | 114,000.00 |
| Apr 30, 2020 | 554,000.00 |
| Jul 31, 2019 | 619,000.00 |
| Apr 30, 2019 | 16,000.00 |
| Jan 31, 2019 | 25,000.00 |
| Oct 31, 2018 | 25,000.00 |
| Jul 31, 2018 | 58,000.00 |
| Apr 30, 2018 | 15,000.00 |
| Jan 31, 2018 | 50,000.00 |
| Oct 31, 2017 | 19,000.00 |
| Jul 31, 2017 | 141,000.00 |
| Apr 30, 2017 | 472,000.00 |